IL131959A0 - Pharmaceutical combined preparations containing erythropoietin and iron preparations - Google Patents

Pharmaceutical combined preparations containing erythropoietin and iron preparations

Info

Publication number
IL131959A0
IL131959A0 IL13195997A IL13195997A IL131959A0 IL 131959 A0 IL131959 A0 IL 131959A0 IL 13195997 A IL13195997 A IL 13195997A IL 13195997 A IL13195997 A IL 13195997A IL 131959 A0 IL131959 A0 IL 131959A0
Authority
IL
Israel
Prior art keywords
preparations
iron
containing erythropoietin
pharmaceutical combined
preparations containing
Prior art date
Application number
IL13195997A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of IL131959A0 publication Critical patent/IL131959A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Clamps And Clips (AREA)
IL13195997A 1997-03-18 1997-03-18 Pharmaceutical combined preparations containing erythropoietin and iron preparations IL131959A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/001343 WO1998041226A1 (de) 1997-03-18 1997-03-18 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (1)

Publication Number Publication Date
IL131959A0 true IL131959A0 (en) 2001-03-19

Family

ID=8166555

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13195997A IL131959A0 (en) 1997-03-18 1997-03-18 Pharmaceutical combined preparations containing erythropoietin and iron preparations
IL131959A IL131959A (en) 1997-03-18 1999-09-16 Combined pharmaceutical preparations containing erythropoietin preparations with less than U2000 and iron preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL131959A IL131959A (en) 1997-03-18 1999-09-16 Combined pharmaceutical preparations containing erythropoietin preparations with less than U2000 and iron preparations

Country Status (19)

Country Link
US (1) US6710028B2 (no)
EP (1) EP0977582B1 (no)
JP (1) JP2000514092A (no)
AT (1) ATE222118T1 (no)
AU (1) AU726801B2 (no)
BR (1) BR9714632A (no)
CA (1) CA2284910C (no)
CZ (1) CZ296960B6 (no)
DE (1) DE59707988D1 (no)
DK (1) DK0977582T3 (no)
ES (1) ES2180958T3 (no)
HU (1) HU226204B1 (no)
IL (2) IL131959A0 (no)
NO (1) NO324661B1 (no)
NZ (1) NZ337465A (no)
PL (1) PL187479B1 (no)
PT (1) PT977582E (no)
SI (1) SI0977582T1 (no)
WO (1) WO1998041226A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US20040198663A1 (en) * 2003-04-04 2004-10-07 Baker John E. Method of treating cardiac ischemia by using erythropoietin
WO2005000340A1 (en) * 2003-06-27 2005-01-06 Pomytkin Igor A Synergistic compositions comprising erythropoietin and succinic acid (salt)
DK1696947T3 (en) * 2003-12-19 2014-03-17 Hoffmann La Roche APPLICATION OF ERYTHROPOIETIN IN THE TREATMENT OF DISORDERS OF THE IRON DISTRIBUTION IN CHRONIC INFLAMMATORY INTESTINAL DISEASES
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
ES2962777T3 (es) 2007-11-15 2024-03-21 Amgen Inc Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
EP2067752A1 (en) * 2007-12-06 2009-06-10 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Construction material
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
ES2667066T3 (es) 2010-05-24 2018-05-09 The Trustees Of Columbia University In The City Of New York Proteínas NGAL mutantes y usos de las mismas
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JP2858752B2 (ja) * 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US20020065214A1 (en) * 2000-11-29 2002-05-30 Adrian Iaina Method of treating congestive heart failure
CA2431964C (en) * 2000-12-20 2013-09-10 F. Hoffmann-La Roche Ag Conjugates of erythropoietin (pep) with polyethylene glycol (peg)

Also Published As

Publication number Publication date
PL335858A1 (en) 2000-05-22
AU726801B2 (en) 2000-11-23
NO324661B1 (no) 2007-11-26
ATE222118T1 (de) 2002-08-15
US20020094948A1 (en) 2002-07-18
HUP0001409A2 (en) 2001-03-28
DK0977582T3 (da) 2002-12-16
JP2000514092A (ja) 2000-10-24
NZ337465A (en) 2002-04-26
CA2284910C (en) 2003-01-28
EP0977582A1 (de) 2000-02-09
EP0977582B1 (de) 2002-08-14
WO1998041226A1 (de) 1998-09-24
PT977582E (pt) 2002-12-31
HUP0001409A3 (en) 2003-08-28
CA2284910A1 (en) 1998-09-24
IL131959A (en) 2006-12-31
PL187479B1 (pl) 2004-07-30
CZ296960B6 (cs) 2006-08-16
NO994511D0 (no) 1999-09-17
NO994511L (no) 1999-09-17
SI0977582T1 (en) 2002-12-31
BR9714632A (pt) 2000-05-23
HU226204B1 (en) 2008-06-30
AU2157297A (en) 1998-10-12
WO1998041226A9 (de) 1999-11-25
CZ9903300A3 (cs) 2001-03-14
ES2180958T3 (es) 2003-02-16
DE59707988D1 (de) 2002-09-19
US6710028B2 (en) 2004-03-23

Similar Documents

Publication Publication Date Title
CA2234282A1 (en) Drug-resin complexes stabilized by chelating agents
AU7128296A (en) Pharmaceutical combination preparations containing erythropoietin and iron preparations
IL131959A0 (en) Pharmaceutical combined preparations containing erythropoietin and iron preparations
AR244827A1 (es) Procedimiento para blanquear material celulosico derivado de pulpa quimica y que tiene enlaces xilosidicos hidrolizables por xilanasa y material resultante.
PH30768A (en) Cosmetic composition for treatment of pimples and redness.
AU4254696A (en) Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
AU2001287850A1 (en) Iron compositions
AU6178198A (en) Method of treating a tumor
WO1996041627A3 (en) Iron compounds, compositions, methods of making the same and uses thereof
AU630245B2 (en) Hydrogen peroxide destroying compositions and methods of using same
CA2294448A1 (en) Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
ATE232243T1 (de) Reduktion von eisenoxyd im drehherdofen
PL322763A1 (en) Levobupivacaine and pplication thereof as anelgetic agent for pregnant women
AUPP823999A0 (en) A treatment
HU912742D0 (en) T-pa pro-stabilization
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
AU8898098A (en) Antimutagenic agents
AU713086C (en) 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation
CA2171460A1 (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
UA10825A (uk) Протимікробhий засіб
UA29683A (uk) Гель для лікування пародонтиту
MX9705119A (es) Interferona modificada quimicamente.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed